No Data
No Data
Roth MKM Maintains Chemomab Therapeutics(CMMB.US) With Buy Rating, Raises Target Price to $9
Express News | Chemomab Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement
ADRs Close Lower; Chemomab Therapeutics Ltd. Declines 16%
Oppenheimer Maintains Chemomab Therapeutics(CMMB.US) With Buy Rating, Raises Target Price to $13
Chemomab Therapeutics to Raise $10 Million From Private Placement; Shares Fall
Express News | Chemomab Therapeutics: Purchase Agreement Post Which Agreed to Sell in Lieu of Adss, Pre-Funded Warrants to Purchase up to 3.1 Mln Adss
No Data
Trytosaveabit OP : Now beat PMHOD and we be tight again![money_with_wings 💸](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f4b8.png)
RoadToMoreMs : Let’s goooo
RoadToMoreMs : You were right
Trytosaveabit OP RoadToMoreMs : Indeed lets
Trytosaveabit OP RoadToMoreMs : Even a blind squirrel gets a nut! Hehehe
View more comments...